Medical News

RSS

Multivitamin supplements can reduce incidence of pre-eclampsia

Pre-eclampsia is a serious complication of pregnancy that currently affects 6-8% of all pregnancies in Australia. Griffith Health Institute researchers have recently found that multivitamin supplements, including those that contain selenium, can reduce the incidence of PE, especially for overweight mothers.

27 Nov 2013

Typhoon survivors in Tacloban vaccinated against measles and polio

Children in Tacloban – the city hit hardest by Typhoon Haiyan – were vaccinated against measles and polio in the first phase of a mass campaign by the Government of the Philippines with support from UNICEF, the World Health Organization, and other partners. They also received Vitamin A supplements to help improve their immunity against infections.

27 Nov 2013

Bioaxial secures funds to market optical microscopy modules

Bioaxial, developers of super-resolved fluorescence microscopy for the extended imaging of live cells, today announces the completion of a EUR 1.9 million (USD 2.7 million) equity investment by three new large investors; Amorcage Technologique Investissement (a fund managed by CEA Investissement), Inserm Transfert Initiative and Viveris Management plus a range of individual investors.

27 Nov 2013

Mass urbanisation brings great health risks in China’s major cities

At the third plenum held earlier this month, the Chinese government announced reforms to further drive urbanisation in China. After already experiencing the largest human migration in history, what are the public health consequences of this mass movement from rural towns to cities?

27 Nov 2013

Anthem Blue Cross exposes 24,500 doctors' social security, tax numbers

In a departure from most medical privacy cases, Anthem Blue Cross said it accidentally posted online Social Security or tax identification numbers for about 24,500 California doctors. .

27 Nov 2013

AARP releases list of tips & questions on caring for aging parents

The turkey is defrosting and family is starting to gather at the house for Thanksgiving. For many families across New York, this is the once-a-year time that they travel from across the nation and, often times, globe to be with loved ones. In addition to enjoying time with family and friends, AARP says it's also prime time to check on older family members and relatives.

27 Nov 2013

Genetics and cardiovascular drugs: an interview with Nancy Lurker, CEO of PDI and Paul Kinnon, CEO of Transgenomic, Inc.

People inherit different versions of any particular gene, and some genes affect how patients process and metabolize medicines. This especially holds true for people with cardiovascular (CV) disease. They may be fast, slow or non-metabolizers and might also react badly (with serious adverse events) to certain drug therapies or not at all.

27 Nov 2013

State exchange news: Oregon's 'epic failure'; Kansas' next steps on canceled policies; rural challenge in Minnesota

Oregon once led the country in implementing Obamacare. Now it's just about dead last. Not one person has yet enrolled in the Cover Oregon insurance exchange - a major embarrassment to state policymakers who early on had wholeheartedly embraced the Affordable Care Act even as other states tried their best to hinder it. ... The uncertainty is leading to fears that Oregonians whose plans have been canceled as of Dec. 31 will find themselves without affordable coverage when the new year begins (Winfield Cunningham, 11/26).

27 Nov 2013

SMART Medical Systems, PENTAX Medical announce strategic pan-European alliance

SMART Medical Systems Ltd., a developer and manufacturer of innovative endoscopy products, and PENTAX Medical, an industry leader in endoscopic imaging, announced a strategic pan-European alliance, under which PENTAX Medical will commercialize SMART's novel G-EYE™ endoscope in Europe, the Middle-East and Africa (EMEA)

27 Nov 2013

FDA grants Orphan Drug Designation to CMC Contrast's CMC-001 MRI contrast media

CMC Contrast AB, a privately owned drug development company that is developing a targeted contrast agent for Magnetic Resonance Imaging (MRI), announced today that Orphan Drug Designation has been granted by the US Food and Drug Administration (FDA) for its liver specific contrast agent CMC-001.

27 Nov 2013

Fluxion Biosciences reports first study results from early stage NSCLC patients

Fluxion Biosciences, Inc. announced the presentation of the first pilot study results aimed at isolating circulating tumor cells (CTCs) from early stage non-small cell lung cancer (NSCLC) patients obtained in collaboration with Dr. Max Diehn's lab at Stanford University. CTCs are cells that disseminate from primary tumors and contribute to the spread of the disease to other parts of the body.

From Fluxion Biosciences 27 Nov 2013

Edison initiates coverage of biotechnology company focused on adult stem therapies

Edison Investment Research, a leading international investment research firm, announces the initiation of coverage of Mesoblast (MSB: ASX), an Australian-headquartered biotechnology company focused on adult stem therapies.

27 Nov 2013

Alpha Biolaboratories launches first accredited next day DNA paternity testing service in UK

A Warrington-based DNA testing laboratory is offering the UK's first standard next day paternity results service and is on a recruitment drive to cope with the anticipated increase in demand.

27 Nov 2013

WHO releases new treatment guidelines for children suffering severe acute malnutrition

WHO today released new treatment guidelines for the almost 20 million children under-five worldwide who have severe acute malnutrition.

27 Nov 2013

Smaller micropolitan areas of the U.S. have very few rheumatologists

A novel study published in the American College of Rheumatology journal, Arthritis & Rheumatism, shows that smaller micropolitan areas of the U.S.-those with less than 50,000 people-have very few or no practicing adult rheumatologist. In some of these areas, individuals have to travel more than 200 miles to reach the closest rheumatologist.

27 Nov 2013

Troubled effort to devise new cholesterol guidelines

The New York Times explores what went wrong as a group of doctors struggled to find common ground on how heart issues should be treated. Other stories also look at consumer frustration about a landmark settlement on hip implants and concerns being reviewed by the FDA about emergency contraceptive pills.

27 Nov 2013

Drug interactions impact use of cholesterol-lowering statin drugs

A new study has found that many people who stopped taking cholesterol-lowering statin drugs were also taking an average of three other drugs that interfered with the normal metabolism of the statins.

27 Nov 2013

Health policy researcher calls for orthopaedic surgeons to implement principles of value-based healthcare

Healthcare expenditures currently account for 18% of the United States Gross Domestic Product (GDP). Some experts have suggested that an emphasis on value may be an effective strategy to evaluate healthcare costs.

27 Nov 2013

Research: Motor proteins transport mRNA to get where it is needed, prevent diseases

Scientists have found that mRNA may travel one way down a cell, then board another, aptly named motor protein, and head in the opposite direction to get where it ultimately needs to be.

27 Nov 2013

OPOs’ efforts to enforce FPA is inconsistent and incomplete, shows study

All 50 states and the District of Columbia have adopted the 2006 Revised Uniform Anatomical Gift Act (UAGA) or enacted similar legislation giving individuals the "First Person Authorization" (FPA) to consent to organ donation after death via a signed donor card or driver's license, or by enrollment in a donor registry.

27 Nov 2013